This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Allen, E. D. Articles by Mccoy, K. S. Search for Related Content PubMed PubMed Citation Articles by Allen, E. D. Articles by Mccoy, K. S. Pubmed/NCBI databases Medline Plus Health Information Cystic Fibrosis Home Care Services Social Bookmarking                         What's this?

Prolonged Parenteral Nutrition for Cystic Fibrosis Patients

The Division of Pulmonary Medicine, Department of Pediatrics and The Nutrition Support Service, Children's Hospital, The Ohio State University, Columbus

Anne B. Mick, BSN

The Division of Pulmonary Medicine, Department of Pediatrics and The Nutrition Support Service, Children's Hospital, The Ohio State University, Columbus

Jennie Nicol, RD

The Division of Pulmonary Medicine, Department of Pediatrics and The Nutrition Support Service, Children's Hospital, The Ohio State University, Columbus

Karen S. Mccoy, MD

The Division of Pulmonary Medicine, Department of Pediatrics and The Nutrition Support Service, Children's Hospital, The Ohio State University, Columbus

To evaluate the clinical impact of prolonged parenteral nutritional (PN) therapy on patients with advanced cystic fibrosis, we conducted a retrospective chart review of 25 cystic fibrosis patients who underwent prolonged PN (median course 295 days) at our institution between August 1988 and May 1992. The patients' survival status, change in percentage of ideal body weight, need for ongoing nutritional intervention, pulmonary function test changes, IV antibiotic use, and complication rates were assessed. Patients gained significant weight while receiving PN, but they lost weight when PN was discontinued. PN did not clearly improve pulmonary status. IV antibiotic therapy nearly doubled during PN. Central venous catheter sepsis rates rose from 1.29 to 3.45 per 1000 catheter days during PN therapy. In conclusion, prolonged PN promotes weight gain in cystic fibrosis patients with severe disease; however, the effect is transient and involves a significantly increased risk of sepsis.

Nutrition in Clinical Practice, Vol. 10, No. 2, 73-79 (1995)
DOI: 10.1177/011542659501000273


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				D. L. Olson and W. F. Schwenk II Nutrition for Patients With Cystic Fibrosis Nutr Clin Pract, December 1, 2004; 19(6): 575 - 580. [Abstract] [Full Text] [PDF]

				A. Munck, S. Malbezin, J. Bloch, M. Gerardin, M. Lebourgeois, J. Derelle, F. Bremont, I. Sermet, M-R. Munck, and J. Navarro Follow-up of 452 totally implantable vascular devices in cystic fibrosis patients Eur. Respir. J., March 1, 2004; 23(3): 430 - 434. [Abstract] [Full Text] [PDF]

				A. A. Ionescu, W. D. Evans, R. J. Pettit, L. S. Nixon, M. D. Stone, and D. J. Shale Hidden Depletion of Fat-Free Mass and Bone Mineral Density in Adults With Cystic Fibrosis Chest, December 1, 2003; 124(6): 2220 - 2228. [Abstract] [Full Text] [PDF]